• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cell loss in the nucleus raphes dorsalis in Alzheimer's disease.

作者信息

Aletrino M A, Vogels O J, Van Domburg P H, Ten Donkelaar H J

机构信息

Department of Anatomy and Embryology, University of Nijmegen, The Netherlands.

出版信息

Neurobiol Aging. 1992 Jul-Aug;13(4):461-8. doi: 10.1016/0197-4580(92)90073-7.

DOI:10.1016/0197-4580(92)90073-7
PMID:1508296
Abstract

Marked neuron loss in the predominantly serotonergic nucleus raphes dorsalis (NRd) in Alzheimer's disease (AD) has repeatedly been reported in the literature. However, most of these studies quantitated only part of the NRd and data were expressed as numerical density. Applying a 3-dimensional sampling scheme throughout the entire rostrocaudal extent of the NRd and sampling neurons regardless of their size and staining characteristics, an overall neuron loss of 39.4% was demonstrated and a tendency for cell shrinkage was likely to be present. No rostrocaudal gradient in neuron loss could be shown. These NRd data are in accordance with neuron loss in other subcortical structures in AD.

摘要

相似文献

1
Cell loss in the nucleus raphes dorsalis in Alzheimer's disease.
Neurobiol Aging. 1992 Jul-Aug;13(4):461-8. doi: 10.1016/0197-4580(92)90073-7.
2
Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons.阿尔茨海默病中的中缝背核:神经原纤维缠结与大神经元缺失
Ann Neurol. 1985 Jun;17(6):573-7. doi: 10.1002/ana.410170608.
3
Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease.阿尔茨海默病中迈内特基底核复合体的细胞丢失和萎缩。
Neurobiol Aging. 1990 Jan-Feb;11(1):3-13. doi: 10.1016/0197-4580(90)90056-6.
4
Neuron loss and shrinkage in the amygdala in Alzheimer's disease.
Neurobiol Aging. 1994 Jan-Feb;15(1):45-54. doi: 10.1016/0197-4580(94)90143-0.
5
Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression.伴有或不伴有抑郁症的老年期抑郁症及阿尔茨海默病中缝背核的神经病理学研究
Am J Psychiatry. 2004 Jun;161(6):1096-102. doi: 10.1176/appi.ajp.161.6.1096.
6
Nucleus raphe dorsalis in parkinsonism-dementia complex of Guam.关岛帕金森病-痴呆综合征中的中缝背核
Acta Neuropathol. 1985;67(3-4):296-9. doi: 10.1007/BF00687815.
7
Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method.额颞叶痴呆:5-羟色胺能而非去甲肾上腺素能上行神经支配受损的证据。采用图像法的免疫细胞化学和定量研究。
Acta Neuropathol. 2001 Mar;101(3):256-70. doi: 10.1007/s004010000293.
8
The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.皮质下核团在阿尔茨海默病型老年痴呆中的不同受累情况。
J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):842-9. doi: 10.1136/jnnp.51.6.842.
9
Spatial analysis of the neuronal density of aminergic brainstem nuclei in primary neurodegenerative and vascular dementia: a comparative immunocytochemical and quantitative study using a graph method.原发性神经退行性痴呆和血管性痴呆中胺能脑干核团神经元密度的空间分析:一项使用图形法的比较免疫细胞化学和定量研究
Anal Cell Pathol. 1999;19(3-4):125-38. doi: 10.1155/1999/256382.
10
The neuropathology of aminergic nuclei in Alzheimer's disease.阿尔茨海默病中胺能核团的神经病理学
Ann Neurol. 1988 Aug;24(2):233-42. doi: 10.1002/ana.410240210.

引用本文的文献

1
Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer's disease.血清素可增强阿尔茨海默病中的神经发生生物标志物、海马体积和认知功能。
Mol Brain. 2024 Dec 18;17(1):93. doi: 10.1186/s13041-024-01169-4.
2
Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans.表达血清素 2C 受体的神经回路调节小鼠和人类的记忆。
Sci Adv. 2024 Jun 28;10(26):eadl2675. doi: 10.1126/sciadv.adl2675.
3
Comprehensive analysis of genetic risk loci uncovers novel candidate genes and pathways in the comorbidity between depression and Alzheimer's disease.
全面分析遗传风险位点揭示了抑郁和阿尔茨海默病共病的新候选基因和途径。
Transl Psychiatry. 2024 Jun 11;14(1):253. doi: 10.1038/s41398-024-02968-y.
4
Poorer aging trajectories are associated with elevated serotonin synthesis capacity.较差的衰老轨迹与升高的血清素合成能力有关。
Mol Psychiatry. 2023 Oct;28(10):4390-4398. doi: 10.1038/s41380-023-02177-x. Epub 2023 Jul 17.
5
Inhibiting 5-hydroxytryptamine receptor 3 alleviates pathological changes of a mouse model of Alzheimer's disease.抑制5-羟色胺受体3可减轻阿尔茨海默病小鼠模型的病理变化。
Neural Regen Res. 2023 Sep;18(9):2019-2028. doi: 10.4103/1673-5374.366492.
6
Understanding How Physical Exercise Improves Alzheimer's Disease: Cholinergic and Monoaminergic Systems.了解体育锻炼如何改善阿尔茨海默病:胆碱能和单胺能系统。
Front Aging Neurosci. 2022 May 18;14:869507. doi: 10.3389/fnagi.2022.869507. eCollection 2022.
7
Examining the Role of the Noradrenergic Locus Coeruleus for Predicting Attention and Brain Maintenance in Healthy Old Age and Disease: An MRI Structural Study for the Alzheimer's Disease Neuroimaging Initiative.探讨蓝斑核去甲肾上腺素能系统在预测健康老年和疾病中注意力和大脑维持中的作用:阿尔茨海默病神经影像学倡议的 MRI 结构研究。
Cells. 2021 Jul 20;10(7):1829. doi: 10.3390/cells10071829.
8
Dysautonomia in Alzheimer's Disease.阿尔茨海默病中的自主神经功能紊乱。
Medicina (Kaunas). 2020 Jul 8;56(7):337. doi: 10.3390/medicina56070337.
9
MGCD0103, a selective histone deacetylase inhibitor, coameliorates oligomeric Aβ -induced anxiety and cognitive deficits in a mouse model.MGCD0103,一种选择性组蛋白去乙酰化酶抑制剂,可改善寡聚体 Aβ诱导的小鼠模型的焦虑和认知缺陷。
CNS Neurosci Ther. 2019 Feb;25(2):175-186. doi: 10.1111/cns.13029. Epub 2018 Jul 5.
10
Therapeutics of Neurotransmitters in Alzheimer's Disease.阿尔茨海默病中神经递质的治疗学
J Alzheimers Dis. 2017;57(4):1049-1069. doi: 10.3233/JAD-161118.